Success Story: NIW Approved Smoothly! Our Expert Team Helped a Postdoctoral Fellow Secure Success

Client’s Testimonial:

“I am happy that I selected Chen’s service for my I-140 application. They have done a fabulous job in all respective services required, and they were very patient and answered my questions correctly to the point. Thank you once again.”

On May 15^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Ethiopia

State of Residence at the Time of Filing: New York

Approval Notice Date: May 15^th, 2025

Processing Time: 19 months, 2 days

Case Summary:

We are pleased to share the approval of an I-140 National Interest Waiver (NIW) petition for our client, a distinguished expert in the field of immunology. The Client holds a Ph.D. in biochemistry, which laid the foundation for his groundbreaking work in immune system regulation. His petition was recently approved, marking an important step in his journey to continue advancing therapies that address pressing public health challenges in the United States.

Research Focus and Contributions

The Client’s proposed endeavor centers on developing engineered human immune cell-based therapies to combat immune-mediated diseases such as inflammatory bowel disease (IBD), type 1 diabetes (T1D), and multiple sclerosis. His work aims to restore regulatory T cell (Treg) function in patients, offering innovative treatment options where existing therapies remain limited.

Key highlights of his contributions include:

Advancing methods for engineering human immune cells to modulate immune tolerance.
Developing therapeutic strategies with the potential to address multiple autoimmune disorders.
Laying the groundwork for translational applications that directly impact human health.

Research Impact and Metrics

The petition highlighted the Client’s significant scholarly achievements and growing influence in the field:

14 peer-reviewed journal articles, including 7 first-authored, which demonstrate his direct leadership in immunology research.
8 first-authored abstracts presented at professional conferences.
382 citations on Google Scholar, reflecting the reliance of independent researchers on his findings to advance their own work.

Expert Recognition

The strength of the Client’s reputation was underscored by four recommendation letters from leading experts in immunology. These letters, including independent voices in the field, attested to the importance of his contributions and the future impact of his research.

“In sum, [Client’s] academic and research history has enabled him to cultivate a rich and unique skillset, making him an invaluable contributor to the fields of biochemistry and immunology.”

National Importance and Support

To further support the petition, we documented evidence of the Client’s funding from respected organizations, including the Government of India’s University Grants Commission and the American Association of Immunologists. These competitive grants underscore both the quality and the global relevance of his research.

NIW Approval and Outlook

The approval of this NIW petition affirms the Client’s exceptional qualifications and the national importance of his work. His efforts to develop immune cell-based therapies address urgent biomedical challenges and align with U.S. national interests in advancing medical research, improving public health, and strengthening the biotechnology sector.

We are proud to have guided the Client through this successful process and look forward to the continued impact of his research in transforming the treatment of immune-mediated diseases.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.